06699.HK
Angelalign Technology Inc.
HKSE · Healthcare · Medical - Instruments & Supplies · CN
HKD 98.70
+3.62%Year over year
Reported trailing growth
- Revenue
- +37.1%
- EBITDA
- +296.6%
- EBIT
- +384.8%
- EPS
- +126.9%
- Free cash flow
- +584.2%
- Operating cash flow
- +360.0%
Forward estimates
Based on analyst estimates
- Revenue
- -12.5%
- EBITDA
- +141.9%
- EPS
- +171.2%
Three-year CAGR
- Revenue
- +26.9%
- EBITDA
- -2.7%
- EBIT
- -8.2%
- Net income
- -2.3%
- EPS
- -2.7%
- Free cash flow
- +116.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025